Medscape

FDA OKs New 'Artificial Pancreas' Medtronic 770G

The US Food and Drug Administration (FDA) has approved the MiniMed 770G (Medtronic) automated insulin delivery system for children aged 2 to 6 years. The 770G will also be available to older children ...
Nasdaq

Medtronic (MDT) Shares Positive Data for MiniMed 780G System

Medtronic plc MDT recently shared a comprehensive set of new data emphasizing the benefits of the MiniMed 780G insulin pump system. The latest findings demonstrate how the system addresses ...
Seeking Alpha

Medtronic leverages data science to launch first-of-its-kind personalized insights program for people living with diabetes

DUBLIN, Oct. 18, 2022 /PRNewswire/ -- Medtronic plc (MDT), the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ ...
Seeking Alpha

New MiniMed™ 780G system data demonstrates ability to address persistent blood sugar challenges for people with type 1 diabetes

With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn ...